Zyprexa, Zydis, Olanzapine News

New data from a 6-month open label randomised controlled trial show INVEGA is associated with significantly less metabolic effects compared to oral olanzapine in people with schizophrenia, while demonstrating comparable efficacy.1 The results were presented at the 15th Biennial Winter Workshop in Psychoses in Barcelona, Spain.

Collectively, Pfizer, Inc. and Eli Lilly & Co. have spent approximately $3.7 billion in settlements this year alone for illegally marketing practices.

What's not to like about global pharmaceutical giant Eli Lilly ? Bears on the stock would point to a number of things.

Previous Presentation: These data debuted at the annual American Psychiatric Association congress in Washington, DC, May 3-8, 2008.

South Carolina, trying to curb abuse of narcotics and save money, is requiring Medicaid patients suspected of doctor-hopping for drugs to choose one pharmacy for all of their prescriptions.

With patent expirations on the horizon and health-care policy in flux, should investors consider a dose of Eli Lilly? It faces a big hit to its revenue as some of its major products like schizophrenia medication Zyprexa go off patent in the next few years.

Up to one third of children and teens who took common antipsychotic drugs for the first time became overweight or obese in as little as 11 weeks, according to new research.

More than a third of children and teenagers taking certain antipsychotic drugs became overweight or obese in the first three months of treatment, a new U.S. study has found.

Children and teens who took antipsychotic medicines in a study gained weight and developed increased blood-fat levels, possibly harming their future health, researchers in New York State said.

Main Category: Psychology / Psychiatry Also Included In: Obesity / Weight Loss / Fitness Mental Health US researchers found that many children and teenagers treated with second generation antipsychotic drugs put on a significant amount of weight and also experienced a worsening of cholesterol and triglyceride levels and other metabolic measures.

Drugs called atypical antipsychotics caused kids to gain an average of 10 to 19 pounds in the first few months.

Many pediatric and adolescent patients who received second-generation antipsychotic medications experienced significant weight gain, along with varied adverse effects on cholesterol and triglyceride levels and other metabolic measures, according to a study in the October 28 issue of JAMA .

Children and teens who take medicines for conditions such as schizophrenia, bipolar disorder and autism tend to put on a substantial amount of weight, a new study finds.

Children on widely used psychiatric drugs can quickly gain an alarming amount of weight; many pack on nearly 20 pounds and become obese within just 11 weeks, a study found.

South Carolina's attorney general said Friday the state has reached a $45 million settlement with drug maker Eli Lilly & Co.

ARE we too quick to prescribe psychotropic medication for emotional and behavioural problems? Take Alzheimer's disease.

KIVI Today's Channel 6 News Idaho reaches $13 million settlement with Eli Lilly The State of Idaho has reached a $13 million settlement with pharmaceutical manufacturer Eli Lilly and Company, Attorney General Lawrence Wasden said.

Drug maker Eli Lilly & Co. has agreed to settle a lawsuit brought by state Attorney General Henry McMaster on behalf of South Carolina.

Connecticut officials say Eli Lilly & Co. has agreed to a $25 million settlement with the state over claims the drugmaker marketed its anti-psychotic drug Zyprexa for unapproved uses and harmed patients.

Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics Export Am J Psychiatry , Vol.